Bharat Parenterals Ltd.
BSE: 541096
₹1,383.95
₹63.05
(4.77%)
As on 22-May-2026IST
Market cap
₹954 Cr
Revenue (TTM)
₹345 Cr
P/E Ratio
--
P/B Ratio
3
Div. Yield
0.1 %
Quality Score
1/10
Growth Score
3/10
Valuation Score
1/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-8 Cr
-
ROE
-16.5 %
-
ROCE
-4.9 %
-
Industry P/E
30.98
-
EV/EBITDA
42.9
-
Debt to Equity
0.4
-
Book Value
₹467.5
-
EPS
₹-11.9
-
Face value
10
-
Shares outstanding
6,891,963
10 Years Aggregate
CFO
₹52.20 Cr
EBITDA
₹187.97 Cr
Net Profit
₹91.54 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
| 14.4 | 14.1 | 25.8 | 23.9 | 61.6 | 29.0 | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
| -19.1 | 85.8 | 147.0 | -14.4 | 2.8 | 109.7 | -20.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bharat Parenterals
|
1,384.0 | 953.8 | 345.4 | -27.3 | -5.3 | -2.5 | -- | 3.0 |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 300.4 | 3,175.8 | 927.1 | 134.7 | 12.8 | 11.2 | 24.6 | 2.7 | |
| 2,028.0 | 15,420.9 | 2,187.2 | 649.7 | 31.5 | 19 | 24 | 4.3 | |
| 1,343.8 | 18,628.3 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.1 | 4.8 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 4,670.8 | 21,395.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.6 | 5.1 | |
| 3,163.2 | 7,289.3 | 1,773.8 | 309.8 | 24.0 | 43.1 | 23.5 | 9.3 | |
| 490.3 | 9,644.1 | 1,538.1 | 226.2 | 20.4 | 9 | 39.6 | 3.9 | |
| 1,153.2 | 10,628.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bharat Parenterals
--
-
Incorporated
1992
-
Chairman
Bharat Desai
-
Managing Director
Bharat Desai
-
Headquarters
Vadodara, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
18-May-2026No News & Announcements are available.
FAQs for Bharat Parenterals
What is the current share price of Bharat Parenterals Ltd Today?
The share price of Bharat Parenterals Ltd is ₹1,383.95 (BSE) as of 22-May-2026 IST. Bharat Parenterals Ltd has given a return of 61.57% in the last 3 years.
What is the current PB & PE ratio of Bharat Parenterals Ltd?
Since, TTM earnings of Bharat Parenterals Ltd is negative, P/E ratio is not available.
The P/B ratio of Bharat Parenterals Ltd is 2.96 times as on 22-May-2026, a 36 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.06
|
|
2024
|
44.99
|
3.31
|
|
2023
|
11.83
|
1.06
|
|
2022
|
9.36
|
1.19
|
|
2021
|
9.42
|
1.34
|
What is the 52 Week High and Low of Bharat Parenterals Ltd?
The 52-week high and low of Bharat Parenterals Ltd are Rs 1,667.20 and Rs 880.25 as of 22-May-2026.
What is the market cap of Bharat Parenterals Ltd?
Bharat Parenterals Ltd has a market capitalisation of ₹ 954 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bharat Parenterals Ltd?
Before investing in Bharat Parenterals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.